220 related articles for article (PubMed ID: 11823886)
1. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Kankaanpää A; Meririnne E; Seppälä T
Psychopharmacology (Berl); 2002 Feb; 159(4):341-50. PubMed ID: 11823886
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
[TBL] [Abstract][Full Text] [Related]
3. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
[TBL] [Abstract][Full Text] [Related]
4. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice.
Nakamura S; Ago Y; Hayashi A; Itoh S; Kakuda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2006 Dec; 60(7):479-84. PubMed ID: 16952156
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
Liu W; Thielen RJ; McBride WJ
Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell.
McMahon LR; Cunningham KA
J Pharmacol Exp Ther; 1999 Oct; 291(1):300-7. PubMed ID: 10490917
[TBL] [Abstract][Full Text] [Related]
9. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
Szumlinski KK; Frys KA; Kalivas PW
Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels.
Mills K; Arsah TA; Ali SF; Shockley DC
Ann N Y Acad Sci; 1998 May; 844():201-7. PubMed ID: 9668678
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
13. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats.
Filip M; Papla I; Nowak E; Jungersmith K; Przegaliński E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705
[TBL] [Abstract][Full Text] [Related]
14. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
Broderick PA; Olabisi OA; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
[TBL] [Abstract][Full Text] [Related]
15. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
Yoo JH; Nam YS; Lee SY; Jang CG
Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity.
Lodge DJ; Grace AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):201-6. PubMed ID: 15784652
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum.
Kankaanpää A; Lillsunde P; Ruotsalainen M; Ahtee L; Seppâlä T
Pharmacol Toxicol; 1996 May; 78(5):317-21. PubMed ID: 8737967
[TBL] [Abstract][Full Text] [Related]
18. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption.
Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Ogata M; Nishimura A; Yoshida T; Ueda S; Komura S
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):311A-319A. PubMed ID: 8986229
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
Kos T; Popik P; Pietraszek M; Schäfer D; Danysz W; Dravolina O; Blokhina E; Galankin T; Bespalov AY
Eur Neuropsychopharmacol; 2006 May; 16(4):297-310. PubMed ID: 16288851
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
Genova LM; Hyman SE
Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
